These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11318882

  • 1. An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.
    Saper JR, Winner PK, Lake AE.
    Headache; 2001 Apr; 41(4):357-68. PubMed ID: 11318882
    [Abstract] [Full Text] [Related]

  • 2. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
    Saper JR, Lake AE, Cantrell DT, Winner PK, White JR.
    Headache; 2002 Jun; 42(6):470-82. PubMed ID: 12167135
    [Abstract] [Full Text] [Related]

  • 3. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

  • 4. A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.
    Lampl C, Marecek S, May A, Bendtsen L.
    Cephalalgia; 2006 Oct; 26(10):1203-8. PubMed ID: 16961787
    [Abstract] [Full Text] [Related]

  • 5. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG.
    CNS Drugs; 2003 Oct; 17(6):373-81. PubMed ID: 12696998
    [Abstract] [Full Text] [Related]

  • 6. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke.
    Gelber DA, Good DC, Dromerick A, Sergay S, Richardson M.
    Stroke; 2001 Aug; 32(8):1841-6. PubMed ID: 11486114
    [Abstract] [Full Text] [Related]

  • 7. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
    Fogelholm R, Murros K.
    Headache; 1992 Nov; 32(10):509-13. PubMed ID: 1468911
    [Abstract] [Full Text] [Related]

  • 8. Modified-release formulation of tizanidine in chronic tension-type headache.
    Murros K, Kataja M, Hedman C, Havanka H, Säkö E, Färkkilä M, Peltola J, Keränen T.
    Headache; 2000 Sep; 40(8):633-7. PubMed ID: 10971659
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [Abstract] [Full Text] [Related]

  • 11. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V, Auriel E, Karni A.
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [Abstract] [Full Text] [Related]

  • 12. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
    Henney HR, Fitzpatrick A, Stewart J, Runyan JD.
    Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
    [Abstract] [Full Text] [Related]

  • 13. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.
    Wagstaff AJ, Bryson HM.
    Drugs; 1997 Mar; 53(3):435-52. PubMed ID: 9074844
    [Abstract] [Full Text] [Related]

  • 14. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group.
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 16. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J, Wesnes KA, Kovelesky RA, Henney HR.
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study.
    Zhang H, Zhang H, Wei Y, Lian Y, Chen Y, Zheng Y.
    Int J Neurosci; 2017 Apr; 127(4):285-290. PubMed ID: 27439999
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M, Tudor IC, Khanna S, Thipphawong J.
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [Abstract] [Full Text] [Related]

  • 19. Tizanidine is not a cure for chronic daily headache.
    Warner JS.
    Headache; 2003 Mar; 43(3):296; author reply 296-7. PubMed ID: 12603653
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.